Target- |
MechanismCell membrane modulators [+1] |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Oryx Southern Delaware Holdings LLC
0 Patents (Medical) associated with Oryx Southern Delaware Holdings LLC
100 Deals associated with Oryx Southern Delaware Holdings LLC
100 Translational Medicine associated with Oryx Southern Delaware Holdings LLC